Delivery Order SPE2DB20D1100-SPE2DB25FE0RG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of ADDYI 100 mg tablets in quantities of 30 tablets per unit, with a ceiling value of $31,068.83. This competitive award utilizes firm fixed pricing and is structured as a delivery order without set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,454.99 on September 16, 2025, for the supply of ADDYI 100 mg tablets in packages of 30. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as one of the nation's...
- The Defense Logistics Agency awarded a delivery order valued at $1,410.28 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets in a quantity of 30 units, with a ceiling value of $11,432.00. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of October 8, 2025. The award was issued on October 7, 2025, with performance to be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $4,889.15 to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of June 2, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,091.21 delivery order on September 8, 2025, for ADDYI (flibanserin) 100 mg tablets in quantities of 30s. This is a firm fixed-price, non-set-aside contract with a completion date of September 9, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of ADDYI (flibanserrin) 100 mg tablets in quantities of 30 units, with a contract ceiling value of $2,030.63. This is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $35,858.57 to AmerisourceBergen Drug Corp for supply of ADDYI 100 mg tablets in quantities of 30-count units. The contract is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and was awarded on September 25, 2025, with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,096.83 to AmerisourceBergen Drug Corp for 30 tablets of ADDYI 100 mg on September 18, 2025, with completion scheduled for September 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,950.27 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) on November 4, 2025, with a completion date of November 5, 2025. This firm fixed-price delivery order is not set-aside and represents a competitively awarded procurement under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0RGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of ADDYI 100 mg tablets in quantities of 30 units, with a ceiling value of $1,935.74. This firm fixed-price delivery order, which is not set-aside, is expected to be completed by September 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare supplier, was competitively selected to fulfill this medical procurement requirement. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency and Medical Supply Chain demonstrates its capability to deliver a wide range of pharmaceutical products to support military healthcare programs. This delivery order for ADDYI, a prescription medication used in the treatment of hypoactive sexual desire disorder in women, aligns with AmerisourceBergen's demonstrated experience supplying specialty medications and brand-name pharmaceuticals to the Department of Defense and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/19/25 |